Related Experiment Video
Updated: Jun 5, 2025
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
295
Severe acute pulmonary embolism in pregnancy
1Royal Surrey NHS Foundation Trust, Guildford, Surrey, UK.
Clinical Medicine (London, England)
|December 15, 2024
Summary
Pulmonary embolism (PE) in pregnancy requires prompt diagnosis and risk stratification. Management includes anticoagulation with low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH), with thrombolysis reserved for severe cases.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Pulmonology
Background:
- Pulmonary embolism (PE) poses significant risks during pregnancy and postpartum.
- Severe PE can lead to hemodynamic instability and cardiac arrest.
- Risk stratification is crucial for managing acute PE.
Purpose of the Study:
- To outline diagnostic and management strategies for intermediate- and high-risk PE in pregnancy.
- To emphasize the applicability of existing PE risk criteria in pregnant patients.
- To discuss safe and effective treatment options for PE during pregnancy and breastfeeding.
Main Methods:
- Focuses on risk stratification criteria for intermediate- and high-risk PE.
- Highlights the importance of timely diagnostic imaging, irrespective of pregnancy.
- Reviews the use of anticoagulants (LMWH, UFH) and thrombolysis in obstetric patients.
Main Results:
- High-risk PE criteria are applicable in pregnancy.
- Diagnostic imaging should not be delayed.
- LMWH and UFH are safe during pregnancy and breastfeeding.
- Systemic thrombolysis is an option for severe, high-risk PE with shock, but carries bleeding risks.
Conclusions:
- Pregnancy and the puerperium are risk factors for PE.
- Avoid premature diagnostic closure; consider alternative diagnoses.
- Appropriate risk stratification and timely intervention are key for managing PE in pregnant patients.
Related Concept Videos
01:26Pneumothorax-I
169
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
169
01:27Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
135
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
135
01:21Acute Respiratory Failure-II
173
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
173
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
147
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
147
01:19Mitral Valve Prolapse III: Nursing Management
1
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
1